|12 Months Ended|
Dec. 31, 2021
|Disclosure of detailed information about intangible assets [abstract]|
Schedule of intangible assets
The amortization charge for the year is recognized within research and development costs in the statements of comprehensive loss.
TC BIOPHARM (HOLDINGS) PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
The entire disclosure for intangible assets.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef